Levels of cytokines and thyroid autoantibodies in Omani patients with Graves' disease

British Journal of Biomedical Science

Volumn 64, Issue 4, 2007, Pages 164-167

  Alnaqdy, A ^a,b   Al Maskari, M ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b Department of Food Science and Nutrition   (Oman)

Author keywords

Autoantibodies; Cytokines; Graves disease; Thyroid gland

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; IODINE 131; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 37849011416     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2007.11732781     Document Type: Article

References (22)

1. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227-57.
2. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-93.
3. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18: 263-6.
4. Collins J, Gough S. Autoimmunity in thyroid disease. Eur J Nucl Med Mol Imaging 2002; 29 (Suppl 2): S417-24.
5. Tonacchera M, van Sande J, Parma J et al. TSH receptor and disease. Clin Endocrinol (Oxf) 1996; 44: 621-33.
6. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 1998; 19: 673-716.
7. Arqueros MC, el Tamer E, el Tamer S, Houssay AB. TSH receptor antibodies as a recurrence index of Graves' disease treated with antithyroid drugs (Spanish). Mediana (B Aires) 1991; 51: 9-13.
8. Weetman AP, Aijan RA, Watson PF. Cytokines and Graves' disease. Bailliere's Clin Endocrinol Metab 1997; 11: 481-97.
9. Ward LS, Fernandes GA. Serum cytokine levels in autoimmune and non-autoimmune hyperthyroid states. Braz J Med Biol Res 2000; 33: 65-9.
10. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation 2004; 11 (4): 209-13.
11. Al-Humaidi MA. Serum cytokine levels in Graves' disease. Saudi Med J 2000; 21: 639-44.
12. Bossowski A, Urban M. Serum levels of cytokines in children and adolescents with Graves' disease and non-toxic goiter J Pediatr Endocrinol Metab 2001; 14: 741-7.
13. Nawroth PP, Banks I, Handley D. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 1986; 163: 1363-75.
14. Bonavida B, Paubert M, Hosford D. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor production in shock. Prog Clin Biol Res 1989; 308: 485-9.
15. Heuer M, Aust G, Ode-Hakim S, Scherbaum WA. Different cytokine profiles in Graves' disease, Hashimoto's thyroiditis and non-autoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996; 6: 97-106.
16. McLachlan SM, Taverne J, Atherton MC. Cytokines, thyroid autoantibody synthesis and thyroid cell survival in culture. Clin Exp Immunol 1990; 79: 175-81.
17. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-73.
18. Feldmann M, Brennan FM, Chantry D et al. Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 1991; 119: 105-23.
19. Feldt-Rasmussen U, Schleusenter H, Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long-term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 1994; 78: 98-102.
20. Mankai A, Toumi D, Chadli-Chaieb M et al. Antithyroid-stimulating hormone receptor antibodies determined by second-generation assay. Clin Chem Lab Med 2007; 45: 26-9.
21. Feldt-Rasmussen U, Bech K, Date J, Petersen PH, Johansen K, Madsen SN. Thyroid stimulating antibodies, thyroglobulin antibodies and serum proteins during antithyroid treatment with radioiodine or propylthiouracil of Graves' disease. Allergy 1982; 32: 161-72.
22. Takamatsu J, Hosoya T, Kohno Y et al. Changes in serum autoantibodies to thyroid peroxidase during antithyroid drug therapy for Graves' disease. Endocrinol Jpn 1990; 37: 275-83.